Catalyst Wire Dossier Catalyst Wire Dossier

TCRαβ+/CD19+ depleted allogeneic hematopoietic stem cell transplantation

TCRαβ+/CD19+ depleted allogeneic hematopoietic stem cell transplantation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TCRαβ+/CD19+ depleted allogeneic hematopoietic stem cell transplantation, covering 2023-09-08 to 2023-09-08. Get the full timeline:

Most recent: Clinical Trial Update: TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disorders [Phase 2]

See pricing